Clik here to view.
Case Study CCRM: How a Canadian company is building a regenerative medicine...
Momentum has been building within the regenerative medicine industry with cell therapies and other technologies moving closer to commercialization every day. With regulatory changes hastening progress...
View ArticleClik here to view.
Stem cell-based test predicts Leukemia patients’ response to therapy to help...
Dr. Jean Wang, Affiliate Scientist at the Princess Margaret Cancer Centre Photo Credit: UHN TORONTO, ON – Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature...
View ArticleClik here to view.
Bayer and Versant team to launch new stem cell startup in Toronto
Bayer AG and Versant Ventures are joined by Federal Minister of Innovation, Science and Economic Development Navdeep Bains and Ontario Premier Kathleen Wynne, to launch USD $225m BlueRock Therapeutics,...
View ArticleClik here to view.
McEwen Centre scientists produce functional heart pacemaker cells
Dr. Stephanie Protze, post-doc fellow and Dr. Gordon Keller, Director of the McEwen Centre for Regenerative Medicine, examine a cell cuture plate with human pacemaker cells generated from pluripotent...
View ArticleClik here to view.
UHN’s Dr. John Dick honoured for ‘tremendous impact’ on cancer research
Dr. John Dick The University Health Network’s Dr. John Dick, a senior scientist at the Princess Margaret Cancer Centre, has received the ISSCR’s Tobias Award Lecture for his leadership in the areas of...
View ArticleClik here to view.
STEMCELL Technologies opens new office and laboratories in Cambridge, UK
VANCOUVER, BC & CAMBRIDGE, England– Vancouver’s STEM CELL Technologies and its subsidiary STEMCELL Technologies UK recently celebrated the grand opening of a new facility in Cambridge,UK. In...
View ArticleClik here to view.
BrainStorm seeks approval to distribute NurOwn® in Canada-signs agreement...
BrainStorm Cell Therapeutics (PRNewsFoto/BrainStorm Cell Therapeutics Inc) TORONTO, ON, HACKENSACK, N.J. & PETACH TIKVAH, ISRAEL, – BrainStorm Cell Therapeutics Inc., a company developing adult...
View ArticleClik here to view.
Gene therapy used to treat Fabry disease – a world first
UCalgary’s Dr. Aneal Khan, left, and the project’s principal investigator Dr. Jeffrey Medin, are hopeful their gene therapy treatment will benefit patients like Darren Bidulka, right. (Photo by Gregory...
View ArticleClik here to view.
New partnership to accelerate development of treatments for neurological...
From left to right: Dr. Sean Smith, Executive Director of Neuroscience Discovery, Merck; Gordon McCauley, President and CEO of CDRD; and Dr. Guy Rouleau, Director of the Montreal Neurological Institute...
View ArticleClik here to view.
ExCellThera wins 2017 MaRS HealthKick challenge investor pitch competition
As part of Toronto Health Innovation Week , MaRS hosted its third annual MaRS HealthKick Challenge where Canada’s top early-stage and emerging growth ventures in medical devices, pharma and biotech,...
View Article
